Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Hall

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Science Immunology|August 9, 2022
CD8 T cells contribute to vaccine protection against SARS-CoV-2 in macaquesJinyan Liu, Jingyou Yu, Katherine McMahan, et al.
NPJ Vaccines|February 23, 2023
Immunogenicity and protective efficacy of GBP510/AS03 vaccine against SARS-CoV-2 delta challenge in rhesus macaquesCatherine Jacob-Dolan, Jingyou Yu, Katherine McMahan, et al.
JACC. Cardiovascular Imaging|November 10, 2022
Short-Term Outcomes After Myopericarditis Related to COVID-19 VaccinationManan Pareek, Jeremy Steele, Jeremy Asnes, et al.
Science Immunology|May 5, 2023
Cytokinopathy with aberrant cytotoxic lymphocytes and profibrotic myeloid response in SARS-CoV-2 mRNA vaccine-associated myocarditisAnis Barmada, Jon Klein, Anjali Ramaswamy, et al.
Pediatric Cardiology|January 13, 2022
Current Practices in Treating Cardiomyopathy and Heart Failure in Duchenne Muscular Dystrophy (DMD): Understanding Care Practices in Order to Optimize DMD Heart Failure Through ACTIONChet Villa, Scott R Auerbach, Neha Bansal, et al.
Cardiology in the Young|February 27, 2025
Cardiac treatment for Duchenne muscular dystrophy: consensus recommendations from the ACTION muscular dystrophy committeePaul Esteso, Scott R Auerbach, Neha Bansal, et al.
Nature Biotechnology|April 24, 2023
A microneedle vaccine printer for thermostable COVID-19 mRNA vaccinesAurélien Vander Straeten, Morteza Sarmadi, John L Daristotle, et al.
Circulation. Heart Failure|December 10, 2019
Baseline Characteristics of the VANISH CohortAnna Axelsson Raja, Ling Shi, Sharlene M Day, et al.
Cell Reports. Medicine|April 6, 2023
Ad26.COV2.S and SARS-CoV-2 spike protein ferritin nanoparticle vaccine protect against SARS-CoV-2 Omicron BA.5 challenge in macaquesJingyou Yu, Paul V Thomas, Michaela Sciacca, et al.
Science Advances|November 23, 2022
Protection against SARS-CoV-2 Omicron BA.1 variant challenge in macaques by prime-boost vaccination with Ad26.COV2.S and SpFNJingyou Yu, Paul V Thomas, Katherine McMahan, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Science Immunology|August 9, 2022
CD8 T cells contribute to vaccine protection against SARS-CoV-2 in macaquesJinyan Liu, Jingyou Yu, Katherine McMahan, et al.
NPJ Vaccines|February 23, 2023
Immunogenicity and protective efficacy of GBP510/AS03 vaccine against SARS-CoV-2 delta challenge in rhesus macaquesCatherine Jacob-Dolan, Jingyou Yu, Katherine McMahan, et al.
JACC. Cardiovascular Imaging|November 10, 2022
Short-Term Outcomes After Myopericarditis Related to COVID-19 VaccinationManan Pareek, Jeremy Steele, Jeremy Asnes, et al.
Science Immunology|May 5, 2023
Cytokinopathy with aberrant cytotoxic lymphocytes and profibrotic myeloid response in SARS-CoV-2 mRNA vaccine-associated myocarditisAnis Barmada, Jon Klein, Anjali Ramaswamy, et al.
Pediatric Cardiology|January 13, 2022
Current Practices in Treating Cardiomyopathy and Heart Failure in Duchenne Muscular Dystrophy (DMD): Understanding Care Practices in Order to Optimize DMD Heart Failure Through ACTIONChet Villa, Scott R Auerbach, Neha Bansal, et al.
Cardiology in the Young|February 27, 2025
Cardiac treatment for Duchenne muscular dystrophy: consensus recommendations from the ACTION muscular dystrophy committeePaul Esteso, Scott R Auerbach, Neha Bansal, et al.
Nature Biotechnology|April 24, 2023
A microneedle vaccine printer for thermostable COVID-19 mRNA vaccinesAurélien Vander Straeten, Morteza Sarmadi, John L Daristotle, et al.
Circulation. Heart Failure|December 10, 2019
Baseline Characteristics of the VANISH CohortAnna Axelsson Raja, Ling Shi, Sharlene M Day, et al.
Cell Reports. Medicine|April 6, 2023
Ad26.COV2.S and SARS-CoV-2 spike protein ferritin nanoparticle vaccine protect against SARS-CoV-2 Omicron BA.5 challenge in macaquesJingyou Yu, Paul V Thomas, Michaela Sciacca, et al.
Science Advances|November 23, 2022
Protection against SARS-CoV-2 Omicron BA.1 variant challenge in macaques by prime-boost vaccination with Ad26.COV2.S and SpFNJingyou Yu, Paul V Thomas, Katherine McMahan, et al.
Pageof 7